Literature DB >> 34087477

Imaging Features of Pulmonary Immune-related Adverse Events.

Chiara Pozzessere1, Romain Lazor2, Raphael Jumeau3, Solange Peters4, John O Prior5, Catherine Beigelman-Aubry6.   

Abstract

Pulmonary immune-related adverse events represent rare but potentially severe side effects of immunotherapies. Diagnosis is often challenging, as symptoms and imaging features are not specific and may mimic other lung diseases, thus potentially delaying appropriate patient management. In this setting, an accurate imaging evaluation is essential for a prompt detection as well as correct management of these drug-induced lung diseases. The purpose of this article is to review the different types of pulmonary immune-related adverse events, describe their imaging characteristics on both HRCT and PET/CT, and stress their underlying diagnostic challenge by presenting the mimickers.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  CTLA-4 antigen; drug-related side effects and adverse reactions; immunotherapy; pneumonitis; programmed cell death 1 receptor

Year:  2021        PMID: 34087477     DOI: 10.1016/j.jtho.2021.05.017

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  2 in total

Review 1.  Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review.

Authors:  Yuxuan Hao; Xiaoye Zhang; Li Yu
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

2.  Case report: Pneumonia with clinical symptoms precedes imaging evidence after immune checkpoint inhibitors combined with radiotherapy in lung squamous cell cancer.

Authors:  Yao Wang; Yimeng Wang; Jinming Yu; Xiangjiao Meng
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.